Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 1/2023

10-01-2022 | Diabetic Retinopathy | Original Article

Role of epicardial fat thickness for prediction of proliferative diabetic retinopathy

Authors: Sincer Abide, Kaygusuz Tuba, Alkan Yunus, Cosgun Mehmet, Dogan Umit, Ulas Fatih, Gunes Yilmaz, Isa Sincer

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2023

Login to get access

Abstract

Purpose

Plenty of factors including inflammation are responsible for development of diabetic retinopathy (DR). Epicardial fat produces adipokines, cytokines and inflammatory products. Monocyte count to high density lipoprotein (HDL) ratio (MHR) has been recently suggested as an inflammatory marker.

Methods

Epicardial fat thickness (EFT) and MHR were analyzed in 36 diabetics without DR (NDR), 35 diabetics with proliferative DR (PDR) and 41 diabetics with nonproliferative DR patients (nonPDR).

Results

Monocyte counts, HDL, mean MHR and EFT values of NDR, nonPDR and PDR groups were significantly different. One-way analysis of variance test with post hoc Tukey test revealed that the significance of differences in MHR and EFT were dependent on the differences between NDR and PDR (p<0.001 for both) and nonPDR and PDR groups (p<0.001 and p=0.001). The differences between NDR and nonPDR (p=0.81 and p=0.06) were not significant. MHR and EFT were significantly positively correlated with PDR (r=0.453, p<0.001 and r=0.394, p<0.001) and negatively correlated with NDR (r=−0.256, p=0.006 and r= −0.380, p<0.001). Only EFT was found to be independently associated with PDR (p=0.002, 95% CI: OR: 1.643 (1.206–2.237)). An EFT value of >5.90 mm classified the presence of PDR with a sensitivity 74% and specificity of 61% (AUC = 0.750, 95% CI, 0.658–0.843), and a MHR value of >12.8 ratio classified the presence of PDR with a sensitivity of 83% and a specificity of 79% (AUC = 0.811, 95% CI, 0.728–0.893).

Conclusion

We suggest that MHR and EFT were significantly increased in proliferative DR, and increased EFT may predict the presence of PDR in type 2 DM.
Literature
1.
go back to reference Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, et al. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes): An International Multicenter Registry. Diabetes Care. 2012;35(8):1787–94.CrossRefPubMedPubMedCentral Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, et al. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes): An International Multicenter Registry. Diabetes Care. 2012;35(8):1787–94.CrossRefPubMedPubMedCentral
2.
go back to reference Rosenson R, Fioretto P, Dodson P. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis. 2011;218(1):13–8.CrossRefPubMed Rosenson R, Fioretto P, Dodson P. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis. 2011;218(1):13–8.CrossRefPubMed
3.
go back to reference Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17(1):50–7.CrossRefPubMed Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17(1):50–7.CrossRefPubMed
5.
go back to reference Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–6.CrossRefPubMed Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–6.CrossRefPubMed
6.
go back to reference Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156–64.CrossRefPubMed Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80(5):1156–64.CrossRefPubMed
7.
go back to reference Li X-P, Zhao S-P, Zhang X-Y, Liu L, Gao M, Zhou Q-C. Protective effect of high-density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol. 2000;73(3):231–6.CrossRefPubMed Li X-P, Zhao S-P, Zhang X-Y, Liu L, Gao M, Zhou Q-C. Protective effect of high-density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol. 2000;73(3):231–6.CrossRefPubMed
8.
go back to reference Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta Lipids Lipid Metab. 1990;1044(2):275–83.CrossRef Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta Lipids Lipid Metab. 1990;1044(2):275–83.CrossRef
9.
go back to reference Cetin MS, Cetin EHO, Kalender E, Aydin S, Topaloglu S, Kisacik HL, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–86.CrossRefPubMed Cetin MS, Cetin EHO, Kalender E, Aydin S, Topaloglu S, Kisacik HL, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 2016;25(11):1077–86.CrossRefPubMed
10.
go back to reference Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–46.CrossRefPubMed Ganjali S, Gotto AM Jr, Ruscica M, Atkin SL, Butler AE, Banach M, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237–46.CrossRefPubMed
11.
go back to reference Buse JB, Wexler DJ, Tsapas A, et al. 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(2):487–93.CrossRefPubMed Buse JB, Wexler DJ, Tsapas A, et al. 2019 Update to: Management of hyperglycemia in type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(2):487–93.CrossRefPubMed
12.
go back to reference Wilkinson C, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.CrossRefPubMed Wilkinson C, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–82.CrossRefPubMed
13.
go back to reference Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–8.CrossRefPubMed Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–8.CrossRefPubMed
14.
go back to reference Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care. 2015;38(7):1356–64.CrossRefPubMed Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, et al. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care. 2015;38(7):1356–64.CrossRefPubMed
15.
go back to reference Afzal N, Zaman S, Shahzad F, Javaid K, Zafar A, Nagi AH. Immune mechanisms in type-2 diabetic retinopathy. J Pak Med Assoc. 2015;65(2):159–63.PubMed Afzal N, Zaman S, Shahzad F, Javaid K, Zafar A, Nagi AH. Immune mechanisms in type-2 diabetic retinopathy. J Pak Med Assoc. 2015;65(2):159–63.PubMed
16.
go back to reference Varma R, Macias GL, Torres M, Klein R, Peña FY, Azen SP, et al. Biologic risk factors associated with diabetic retinopathy: The Los Angeles Latino Eye Study. Ophthalmology. 2007;114(7):1332–40.CrossRefPubMed Varma R, Macias GL, Torres M, Klein R, Peña FY, Azen SP, et al. Biologic risk factors associated with diabetic retinopathy: The Los Angeles Latino Eye Study. Ophthalmology. 2007;114(7):1332–40.CrossRefPubMed
17.
go back to reference Powell EU, Field R. Diabetic retinopathy and rheumatoid arthritis. Lancet. 1964;284(7349):17–8.CrossRef Powell EU, Field R. Diabetic retinopathy and rheumatoid arthritis. Lancet. 1964;284(7349):17–8.CrossRef
18.
go back to reference Sasongko M, Wong T, Jenkins A, Nguyen T, Shaw J, Wang J. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med. 2015;32(5):686–91.CrossRefPubMed Sasongko M, Wong T, Jenkins A, Nguyen T, Shaw J, Wang J. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. Diabet Med. 2015;32(5):686–91.CrossRefPubMed
19.
go back to reference Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006;91(11):4620–7.CrossRefPubMed Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z, et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006;91(11):4620–7.CrossRefPubMed
20.
go back to reference Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43(12):1651–4.CrossRefPubMed Iacobellis G, Malavazos AE, Corsi MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol. 2011;43(12):1651–4.CrossRefPubMed
21.
go back to reference Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011;214:3–10.CrossRefPubMed Verhagen SN, Visseren FL. Perivascular adipose tissue as a cause of atherosclerosis. Atherosclerosis. 2011;214:3–10.CrossRefPubMed
22.
go back to reference Turan E, Kırboğa K, Turan Y, Göçmen AY. Pentraxin 3 and epicardial fat thickness are independently associated with diabetic retinopathy in diabetic patients. Int J Diabetes Dev Ctries. 2019;39:499–505.CrossRef Turan E, Kırboğa K, Turan Y, Göçmen AY. Pentraxin 3 and epicardial fat thickness are independently associated with diabetic retinopathy in diabetic patients. Int J Diabetes Dev Ctries. 2019;39:499–505.CrossRef
23.
go back to reference Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794–801.PubMedPubMedCentral Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794–801.PubMedPubMedCentral
24.
go back to reference Bolayir A, Gokce SF, Cigdem B, Bolayır HA, Yildiz OK, Bolayir E, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52:150-5.25.CrossRefPubMed Bolayir A, Gokce SF, Cigdem B, Bolayır HA, Yildiz OK, Bolayir E, et al. Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients. Neurol Neurochir Pol. 2018;52:150-5.25.CrossRefPubMed
26.
go back to reference Liu H, Lui K, Pei L, Gao Y, Zhao L, Sun S, et al. Monocyte-to-high-density lipoprotein ratio predicts the outcome of acute ıschemic stroke. J Atheroscler Thromb. 2020;27(9):959–68.CrossRefPubMedPubMedCentral Liu H, Lui K, Pei L, Gao Y, Zhao L, Sun S, et al. Monocyte-to-high-density lipoprotein ratio predicts the outcome of acute ıschemic stroke. J Atheroscler Thromb. 2020;27(9):959–68.CrossRefPubMedPubMedCentral
27.
go back to reference Uslu AU, Sekin Y, Tarhan G, Canakcı N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2018;24(5):828–33.CrossRefPubMed Uslu AU, Sekin Y, Tarhan G, Canakcı N, Gunduz M, Karagulle M. Evaluation of monocyte to high-density lipoprotein cholesterol ratio in the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2018;24(5):828–33.CrossRefPubMed
28.
go back to reference Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80:1156–64.CrossRefPubMed Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol. 2006;80:1156–64.CrossRefPubMed
29.
go back to reference Tong PC, Lee K-F, So W-Y, et al. White blood cell count isassociated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–22.CrossRefPubMed Tong PC, Lee K-F, So W-Y, et al. White blood cell count isassociated with macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004;27:216–22.CrossRefPubMed
30.
go back to reference Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37:710–8.CrossRefPubMed Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37:710–8.CrossRefPubMed
31.
go back to reference Acikgoz N, Kurtoğlu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology. 2018;69(1):65–70.CrossRefPubMed Acikgoz N, Kurtoğlu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology. 2018;69(1):65–70.CrossRefPubMed
Metadata
Title
Role of epicardial fat thickness for prediction of proliferative diabetic retinopathy
Authors
Sincer Abide
Kaygusuz Tuba
Alkan Yunus
Cosgun Mehmet
Dogan Umit
Ulas Fatih
Gunes Yilmaz
Isa Sincer
Publication date
10-01-2022
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2023
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-021-01040-5

Other articles of this Issue 1/2023

International Journal of Diabetes in Developing Countries 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine